Unknown

Dataset Information

Pan-selectin inhibitors as potential therapeutics for COVID-19 treatment: in silico screening study.


ABSTRACT: Coronavirus disease 2019 (COVID-19) has spread rapidly throughout the globe. The spectrum of disease is broad but among hospitalized patients with COVID-19, respiratory failure from acute respiratory distress syndrome is the leading cause of mortality. There is an urgent need for an effective treatment. The current focus has been developing novel therapeutics, including antivirals, protease inhibitors, vaccines and targeting the overactive cytokine response with anti-cytokine therapy. The overproduction of early response proinflammatory cytokines results in what has been described as a "cytokine storm" is leading eventually to death when the cells fail to terminate the inflammatory response. Accumulating evidence shows that inflammatory cytokines induce selectin ligands that play a crucial

SUBMITTER: Smak P 

PROVIDER: S-EPMC8083503 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature